Ulrike Naumann Selected Research

Brain Injuries (Brain Injury)

6/2020

A Single Injection of N-Oleoyldopamine, an Endogenous Agonist for Transient Receptor Potential Vanilloid-1, Induced Brain Hypothermia, but No Neuroprotective Effects in Experimentally Induced Cerebral Ischemia in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulrike Naumann Research Topics

Disease

34	Neoplasms (Cancer) 01/2024 - 01/2003
28	Glioma (Gliomas) 11/2023 - 01/2002
16	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 01/2002
4	Brain Neoplasms (Brain Tumor) 09/2022 - 09/2013
3	Melanoma (Melanoma, Malignant) 01/2024 - 03/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 02/2006
1	Coffin-Siris syndrome 02/2024
1	Myotonic Dystrophy (Dystrophia Myotonica) 11/2023
1	Muscular Dystrophies (Muscular Dystrophy) 11/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2023
1	Sickle Cell Anemia (Hemoglobin S Disease) 08/2023
1	Pain (Aches) 01/2023
1	Alopecia (Baldness) 01/2023
1	Hidradenitis Suppurativa 01/2023
1	Chest Pain (Chest Pains) 01/2023
1	Constipation 01/2023
1	Cough 01/2023
1	Diarrhea 01/2023
1	Dyspnea (Shortness of Breath) 01/2023
1	Fatigue 01/2023
1	Vomiting 01/2023
1	Skin Diseases (Skin Disease) 01/2023
1	Nausea 01/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2021
1	Sarcopenia 01/2021
1	Multiple Sclerosis 01/2021
1	Vesicular Stomatitis 01/2021
1	Inflammation (Inflammations) 01/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021
1	Measles 01/2021
1	Atrophy 01/2021
1	Vaccinia 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 10/2020
1	Brain Injuries (Brain Injury) 06/2020
1	Brain Ischemia (Cerebral Ischemia) 06/2020
1	Hyperthermia 06/2020
1	Hypothermia 06/2020

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2002
7	LigandsIBA 01/2023 - 01/2003
6	CytokinesIBA 10/2021 - 01/2006
6	Transforming Growth Factor beta (TGF-beta)IBA 01/2015 - 11/2004
5	Transcription Factors (Transcription Factor)IBA 10/2021 - 12/2009
4	viscum album peptide (Iscador)IBA 01/2019 - 01/2012
3	Messenger RNA (mRNA)IBA 11/2023 - 08/2005
3	RNA (Ribonucleic Acid)IBA 03/2021 - 01/2021
3	Viscum ribosome inactivating proteinIBA 01/2019 - 02/2017
3	Carboxypeptidase H (Carboxypeptidase E)IBA 09/2017 - 07/2012
3	Matrix Metalloproteinases (MMPs)IBA 08/2017 - 02/2011
3	NF-kappa B (NF-kB)IBA 11/2015 - 03/2010
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2013
2	TRAM 34IBA 11/2023 - 12/2022
2	Lysine (L-Lysine)FDA Link 01/2023 - 03/2020
2	Temozolomide (Temodar)FDA LinkGeneric 12/2022 - 01/2018
2	EnzymesIBA 02/2021 - 07/2012
2	Therapeutic UsesIBA 10/2019 - 02/2011
2	Glucose (Dextrose)FDA LinkGeneric 09/2017 - 07/2012
2	LectinsIBA 02/2017 - 01/2012
2	InterleukinsIBA 11/2015 - 01/2004
2	Histone Deacetylase InhibitorsIBA 08/2013 - 04/2013
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 06/2011 - 03/2010
2	Phosphotransferases (Kinase)IBA 02/2011 - 01/2006
2	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 10/2008 - 01/2006
2	micaIBA 02/2006 - 12/2003
2	DecorinIBA 01/2006 - 11/2004
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2024
1	Inositol (Myoinositol)IBA 01/2024
1	Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA 11/2023
1	GlobinsIBA 08/2023
1	Fetal Hemoglobin (Hemoglobin F)IBA 08/2023
1	Hemoglobins (Hemoglobin)IBA 08/2023
1	PlatinumIBA 01/2023
1	AutoantibodiesIBA 01/2023
1	AntibodiesIBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	cemiplimabIBA 01/2023
1	Radiation-Sensitizing AgentsIBA 12/2022
1	Potassium Channels (Potassium Channel)IBA 12/2022
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2021
1	Asparaginase (Elspar)FDA Link 02/2021
1	AsparagineIBA 02/2021
1	ProteomeIBA 02/2021
1	pleiotrophin (HARP)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	3- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA 06/2020
1	N-oleoyldopamineIBA 06/2020
1	Neuroprotective AgentsIBA 06/2020

Therapy/Procedure

22	Therapeutics 01/2023 - 01/2003
5	Drug Therapy (Chemotherapy) 01/2023 - 09/2003
4	Immunotherapy 04/2013 - 12/2003
3	Radiotherapy 01/2006 - 01/2002
2	Investigational Therapies (Experimental Therapy) 10/2008 - 02/2006
1	Heterologous Transplantation (Xenotransplantation) 08/2023
1	Lasers (Laser) 01/2021
1	Denervation 01/2021
1	Intranasal Administration 10/2020
1	Transplantation 10/2020
1	Induced Hypothermia 06/2020